Follow

Eurocine Vaccines AB

Spotlight Stock Market (Sweden)

Eurocine Vaccines is a development company in the highly intense vaccine area, bridging the gap between innovation and market. Through its portfolio strategy, innovative vaccine candidates are given the opportunity to reach the market quicker, while investors are offered risk diversification with a big future leverage. These candidates are later licensed to partners for commercialization.
The company is in the possession of its own technology platform, Endocine™, which has been tested in four extensive c
Eurocine Vaccines is a development company in the highly intense vaccine area, bridging the gap between innovation and market. Through its portfolio strategy, innovative vaccine candidates are given the opportunity to reach the market quicker, while investors are offered risk diversification with a big future leverage. These candidates are later licensed to partners for commercialization.
The company is in the possession of its own technology platform, Endocine™, which has been tested in four extensive clinical studies with over 400 subjects.
Listed at Spotlight Stock Market, XSAT, Eurocine Vaccines, EUCI, today operates at the heart of the bio-scientific cluster of Karolinska Institutet, Solna, Sweden and has attracted several internationally merited vaccine specialists to its board.
Read more

Sector:
HEALTH CARE
>
Pharmaceuticals
Pharmaceuticals, Biotechnology & Life Sciences
Rights issue
Price
4.00 SEK
Subscription period
07 Jun - 21 Jun 2021
View Details
News
11 Jun 2021 - 07:50
1 2 3 4 5
Show

40

Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
EUCI
SE0015382155
Spotlight Stock Market
Sweden (SE)
Details of share in Eurocine Vaccines AB with ticker EUCI
Status
Active
Order book id
4102
Amount of instruments
7 895 413
Par value
0.2500
Currency
SEK
First trading date
12 Dec 2006
Type
Price
Pre-money
Time
Files
IPO
4.80 SEK
13.68M SEK
16 Oct - 13 Nov 2006
IPO in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
16 Oct - 13 Nov 2006
Subscription price
4.80 SEK
Price per share
4.80 SEK
Target to raise
10 200 000 SEK
Types
Share issue
Pre-money valuation
13.68M SEK
Subscription block size
Minimum subscription
1 000
Record date
Offer status
Closed
Listing status
Listed
First trading date
12 Dec 2006
Issue terms
Open to the public.
Comments for offer & related information
The Company issues between 2.150.000 - 3.125.000 new shares.
Comments for listing & related information
Eurocine Vaccines AB is scheduled to be listed at AktieTorget on December 12, 2006.
Result of offer
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
16.00 SEK
108.32M SEK
11 Oct - 26 Oct 2007
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
11 Oct - 26 Oct 2007
Subscription price
16.00 SEK
Price per share
16.00 SEK
Target to raise
27 080 000 SEK
Types
Share issue
Pre-money valuation
108.32M SEK
Subscription block size
200
Minimum subscription
Record date
09 Oct 2007
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 1:4. Shareholders receive one (1) Subscription Right for every share held on the record date. Four (4) Subscription Rights entitles to subscribe for one (1) new share in the Company.
Comments for offer & related information
The Company issues 1.692.500 new shares. The Rights issue is secured via subscription commitments for SEK 21.7 million, corresponding to 80.3 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 105 percent.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
23.00 SEK
194.64M SEK
19 Feb - 05 Mar 2010
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
19 Feb - 05 Mar 2010
Subscription price
23.00 SEK
Price per share
23.00 SEK
Target to raise
9 731 800 SEK
Types
Share issue
Pre-money valuation
194.64M SEK
Subscription block size
200
Minimum subscription
Record date
16 Feb 2010
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 1:20. Shareholders receive one (1) Subscription Right for every share held on the record date. Twenty (20) Subscription Rights entitles to subscribe for one (1) new share in the Company.
Comments for offer & related information
Result of offer
The Rights issue subscription ratio corresponded to 252 percent.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
19.00 SEK
168.94M SEK
17 Jan - 31 Jan 2011
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
17 Jan - 31 Jan 2011
Subscription price
19.00 SEK
Price per share
19.00 SEK
Target to raise
21 117 000 SEK
Types
Share issue
Pre-money valuation
168.94M SEK
Subscription block size
Minimum subscription
Record date
12 Jan 2011
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 1:8. Shareholders receive one (1) Subscription Right for every share held on the record date. Eight (8) Subscription Rights entitles to subscribe for one (1) new share in the Company.
Comments for offer & related information
The Company issues 1.111.426 new shares. The Rights issue is secured via subscription commitments for SEK 15 million, corresponding to 71 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 152 percent.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
17.00 SEK
180.29M SEK
01 Jun - 15 Jun 2012
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
01 Jun - 15 Jun 2012
Subscription price
17.00 SEK
Price per share
17.00 SEK
Target to raise
30 048 600 SEK
Types
Share issue
Pre-money valuation
180.29M SEK
Subscription block size
Minimum subscription
Record date
28 May 2012
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 1:6. Shareholders receive one (1) Subscription Right for every share held on the record date. Six (6) Subscription Rights entitles to subscribe for one (1) new share in the Company.
Comments for offer & related information
The Company issues 1.767.570 shares. The Rights issue is secured via subscription commitments and guarantee commitments for SEK 22 million, corresponding to 73.2 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 73.2 percent.
Other documents
Type
Price
Pre-money
Time
Files
Directed issue
6.50 SEK
77.35M SEK
11 Feb 2014
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription date
11 Feb 2014
Subscription price
Price per share
6.50 SEK
Target to raise
7 646 400 SEK
Types
Share issue
Pre-money valuation
77.35M SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed share issue towards to the US institution.
Comments for offer & related information
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
2.65 SEK
34.65M SEK
14 Apr - 28 Apr 2015
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
14 Apr - 28 Apr 2015
Subscription price
2.65 SEK
Price per share
2.65 SEK
Target to raise
23 100 700 SEK
Types
Share issue
Pre-money valuation
34.65M SEK
Subscription block size
Minimum subscription
Record date
10 Apr 2015
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 2:3. Shareholders receive one (1) Subscription Right for every share held on the record date. Three (3) Subscription Rights entitles to subscribe for two (2) new shares in the Company.
Comments for offer & related information
The Company issues 8.717.273 new shares. The Rights issue is 100 percent secured via guarantee commitments.
Result of offer
The Rights issue subscription ratio corresponded to 100 percent.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
1.10 SEK
23.97M SEK
25 Feb - 09 Mar 2016
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
25 Feb - 09 Mar 2016
Subscription price
1.10 SEK
Price per share
1.10 SEK
Target to raise
17 979 300 SEK
Types
Share issue
Pre-money valuation
23.97M SEK
Subscription block size
Minimum subscription
Record date
23 Feb 2016
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 3:4. Shareholders receive one (1) Unit Right for every share held on the record date. Four (4) Unit Rights entitles to subscribe for three (3) Units. One (1) Unit consists of one (1) share and one (1) free of charge warrant of series TO1.
Comments for offer & related information
The Company issues 16.344.887 Units. One (1) Unit consists of one (1) share and one (1) free of charge warrant of series TO1. One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to seventy (70) percent of a volume-weighted average share price during the period October 3, 2016 - October 14, 2016. The subscription of shares with the support of warrants will take place during the period from October 17, 2016 - October 28, 2016.
The Rights issue is 100 percent secured via subscription commitments and guarantee commitments.
Other documents
Type
Price
Pre-money
Time
Files
Exercise
2.34 SEK
151.71M SEK
17 Oct - 28 Oct 2016
Option exercise terms for EUCI TO1
Former ticker
EUCI TO 1
Market
Spotlight Stock Market
Exercise period(s)
17 Oct - 28 Oct 2016
Exercise price
2.34 SEK
Status
Closed
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to seventy (70) percent of a volume-weighted average share price during the period October 3, 2016 - October 14, 2016. The subscription of shares with the support of warrants will take place during the period from October 17, 2016 - October 28, 2016.
Update (17.10.2016): Eurocine Vaccines initiates the exercise of warrants TO1 at the price of SEK 2.34.
Update (21.10.2016): Last day for trading with warrants TO1 is October 26, 2016.
Result of offer
Eurocine Vaccines´ warrants of series TO1 subscription ratio corresponded to 94 percent.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
2.34 SEK
125.09M SEK
28 Nov - 12 Dec 2017
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
28 Nov - 12 Dec 2017
Subscription price
2.34 SEK
Price per share
2.34 SEK
Target to raise
41 697 800 SEK
Types
Share issue
Pre-money valuation
125.09M SEK
Subscription block size
Minimum subscription
Record date
24 Nov 2017
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 1:3. Shareholders receive one (1) Unit Right for every share held on the record date. Three (3) Unit Rights entitles to subscribe for one (1) Unit. One (1) Unit consists of one (1) share and one (1) warrant of serie TO2.
Comments for offer & related information
The Company issues 17.819.573 units. One (1) Unit consists of one (1) share and one (1) warrant of serie TO2. One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the volume weighted average trading price during the period November 12, 2018 - November 23, 2018. Subscription with the support of the warrants will take place during the period November 26, 2018 - December 7, 2018.
The Rights issue is secured via subscription commitments and guarantee commitments for SEK 32.8 million, corresponding to 78.6 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 78.6 percent.
Other documents
Type
Price
Pre-money
Time
Files
Exercise
0.24 SEK
16.3M SEK
26 Nov - 07 Dec 2018
Option exercise terms for EUCI TO2
Former ticker
EUCI TO 2
Market
Spotlight Stock Market
Exercise period(s)
26 Nov - 07 Dec 2018
Exercise price
0.24 SEK
Status
Closed
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the volume weighted average trading price during the period November 12, 2018 - November 23, 2018. Subscription with the support of the warrants will take place during the period November 26, 2018 - December 7, 2018.
Update (24.01.2018): Trading in warrants series TO2 will commence on January 31, 2018.
Update (26.11.2018): The subscription price has been calculated - SEK 0.24.
Result of offer
Eurocine Vaccines´ warrants of series TO2 subscription ratio corresponded to 24 percent.
Other documents
Type
Price
Pre-money
Time
Files
Set-off issue
0.24 SEK
17.1M SEK
20 Dec 2018
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription date
20 Dec 2018
Subscription price
Price per share
0.24 SEK
Target to raise
Types
Share issue
Pre-money valuation
17.1M SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Set-off issue related with VisMederi Srl.
Comments for offer & related information
The Company issues 13.652.101 new shares for SEK 3.276.504.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
0.11 SEK
9.34M SEK
25 Mar - 08 Apr 2019
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
25 Mar - 08 Apr 2019
Subscription price
0.11 SEK
Price per share
0.11 SEK
Target to raise
15 562 900 SEK
Types
Share issue
Pre-money valuation
9.34M SEK
Subscription block size
Minimum subscription
Record date
21 Mar 2019
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 5:3. Shareholders receive one (1) Subscription Right for every share held on the record date. Three (3) Subscription Rights entitles to subscribe for five (5) new shares in the Company.
Comments for offer & related information
The Company issues 141.481.780 new shares. The Rights issue is secured via subscription commitments for SEK 14 million, corresponding to 90 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 90.1 percent.
Other documents
Type
Price
Pre-money
Time
Files
Directed issue
0.1187 SEK
25.2M SEK
14 Oct 2019
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription date
14 Oct 2019
Subscription price
Price per share
0.1187 SEK
Target to raise
2 374 000 SEK
Types
Share issue
Pre-money valuation
25.2M SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed share issue towards to Fårö Capital AB and Eastbridge Capital AB.
Comments for offer & related information
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
0.053 SEK
12.31M SEK
21 Jan - 04 Feb 2020
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
21 Jan - 04 Feb 2020
Subscription price
0.318 SEK
Price per share
0.053 SEK
Target to raise
14 775 200 SEK
Types
Share issue
Pre-money valuation
12.31M SEK
Subscription block size
Minimum subscription
Record date
16 Jan 2020
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 6:5. Shareholders receive one (1) Unit Right for every share held on the record date. Five (5) Unit Rights entitles to subscribe for one (1) Unit. One (1) Unit consists of six (6) shares and six (6) free of charge warrants of series TO3.
Comments for offer & related information
The Company issues up to 46.462.990 Units. One (1) Unit consists of six (6) shares and six (6) free of charge warrants of series TO3. One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to (70) percent of the average volume-weighted price during 10 trading days ending before the exercise period begins. The subscription with the support of warrants will take place from June 1, 2020 - June 12, 2020.
The Rights issue is secured via subscription commitments and guarantee commitments for SEK 3.02 million, corresponding to 21 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 164 percent.
Other documents
Type
Price
Pre-money
Time
Files
Exercise
0.087 SEK
61.3M SEK
01 Jun - 12 Jun 2020
Option exercise terms for EUCI TO3
Former ticker
EUCI TO 3
Market
Spotlight Stock Market
Exercise period(s)
01 Jun - 12 Jun 2020
Exercise price
0.087 SEK
Status
Closed
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to (70) percent of the average volume-weighted price during 10 trading days ending before the exercise period begins. The subscription with the support of warrants will take place from June 1, 2020 - June 12, 2020.
Update (26.05.2020): Eurocine Vaccines has agreed on subscription links and guarantee subscriptions corresponding to approximately 28 percent of the issue volume for TO3.
Update (29.05.2020): Eurocine Vaccines announces subscription price for warrants of series TO3 - SEK 0.087.
Update (10.06.2020): The last day for exercise of warrants TO3 is June 12, 2020.
Result of offer
Eurocine Vaccines´ warrants of series TO3 subscription ratio corresponded to 72 percent.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
4.00 SEK
31.58M SEK
07 Jun - 21 Jun 2021
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
07 Jun - 21 Jun 2021
Subscription price
8.00 SEK
Price per share
4.00 SEK
Target to raise
31 581 600 SEK
Types
Share issue
Pre-money valuation
31.58M SEK
Subscription block size
Minimum subscription
Record date
03 Jun 2021
Offer status
Active
Listing status
Listed
 
Issue terms
Rights issue. Preferential right 1:1. Shareholders receive one (1) Unit Right for every share held on the record date. One (1) Unit Right entitles to subscribe for one (1) Unit. One (1) Unit consists of two (2) shares and one (1) free of charge warrant of series TO4.
Comments for offer & related information
The Company issues 3.947.706 Units. One (1) Unit consists of two (2) shares and one (1) free of charge warrant of series TO4. One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the average volume-weighted trading price during the period of ten (10) trading days ending two (2) banking days before exercise period begins, but not higher than SEK 5.0 per share. Subscription with the support of warrants will take place from March 14, 2022 - March 28, 2022.
The Rights issue is secured via subscription commitments and guarantee commitments for SEK 25 million, corresponding to 80 percent from the issue volume.
Update (11.06.2021): Interviews with CEO Hans Arwidsson.
Other documents
Type
Ticker
ISIN
Market
OPTION
EUCI TO4
Spotlight Stock Market
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO4
Status
Inactive
Order book id
Amount of instruments
Currency
SEK
First trading date
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the average volume-weighted trading price during the period of ten (10) trading days ending two (2) banking days before exercise period begins, but not higher than SEK 5.0 per share.
Type
Price
Pre-money
Time
Files
Exercise
14 Mar - 28 Mar 2022
Option exercise terms for EUCI TO4
Former ticker
EUCI TO4-A-2021
Market
Spotlight Stock Market
Exercise period(s)
14 Mar - 28 Mar 2022
Exercise price
Status
Upcoming
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the average volume-weighted trading price during the period of ten (10) trading days ending two (2) banking days before exercise period begins, but not higher than SEK 5.0 per share.
Other documents
Type
Ticker
ISIN
Market
SHARE
EUCI
SE0001839069
Spotlight Stock Market
Sweden (SE)
Details of share in Eurocine Vaccines AB with ticker EUCI
Status
Archived
Order book id
4102
Amount of instruments
789 541 214
Par value
0.0025
Currency
SEK
First trading date
12 Dec 2006
Type
Price
Pre-money
Time
Files
IPO
4.80 SEK
13.68M SEK
16 Oct - 13 Nov 2006
IPO in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
16 Oct - 13 Nov 2006
Subscription price
4.80 SEK
Price per share
4.80 SEK
Target to raise
10 200 000 SEK
Types
Share issue
Pre-money valuation
13.68M SEK
Subscription block size
Minimum subscription
1 000
Record date
Offer status
Closed
Listing status
Listed
First trading date
12 Dec 2006
Issue terms
Open to the public.
Comments for offer & related information
The Company issues between 2.150.000 - 3.125.000 new shares.
Comments for listing & related information
Eurocine Vaccines AB is scheduled to be listed at AktieTorget on December 12, 2006.
Result of offer
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
16.00 SEK
108.32M SEK
11 Oct - 26 Oct 2007
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
11 Oct - 26 Oct 2007
Subscription price
16.00 SEK
Price per share
16.00 SEK
Target to raise
27 080 000 SEK
Types
Share issue
Pre-money valuation
108.32M SEK
Subscription block size
200
Minimum subscription
Record date
09 Oct 2007
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 1:4. Shareholders receive one (1) Subscription Right for every share held on the record date. Four (4) Subscription Rights entitles to subscribe for one (1) new share in the Company.
Comments for offer & related information
The Company issues 1.692.500 new shares. The Rights issue is secured via subscription commitments for SEK 21.7 million, corresponding to 80.3 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 105 percent.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
23.00 SEK
194.64M SEK
19 Feb - 05 Mar 2010
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
19 Feb - 05 Mar 2010
Subscription price
23.00 SEK
Price per share
23.00 SEK
Target to raise
9 731 800 SEK
Types
Share issue
Pre-money valuation
194.64M SEK
Subscription block size
200
Minimum subscription
Record date
16 Feb 2010
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 1:20. Shareholders receive one (1) Subscription Right for every share held on the record date. Twenty (20) Subscription Rights entitles to subscribe for one (1) new share in the Company.
Comments for offer & related information
Result of offer
The Rights issue subscription ratio corresponded to 252 percent.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
19.00 SEK
168.94M SEK
17 Jan - 31 Jan 2011
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
17 Jan - 31 Jan 2011
Subscription price
19.00 SEK
Price per share
19.00 SEK
Target to raise
21 117 000 SEK
Types
Share issue
Pre-money valuation
168.94M SEK
Subscription block size
Minimum subscription
Record date
12 Jan 2011
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 1:8. Shareholders receive one (1) Subscription Right for every share held on the record date. Eight (8) Subscription Rights entitles to subscribe for one (1) new share in the Company.
Comments for offer & related information
The Company issues 1.111.426 new shares. The Rights issue is secured via subscription commitments for SEK 15 million, corresponding to 71 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 152 percent.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
17.00 SEK
180.29M SEK
01 Jun - 15 Jun 2012
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
01 Jun - 15 Jun 2012
Subscription price
17.00 SEK
Price per share
17.00 SEK
Target to raise
30 048 600 SEK
Types
Share issue
Pre-money valuation
180.29M SEK
Subscription block size
Minimum subscription
Record date
28 May 2012
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 1:6. Shareholders receive one (1) Subscription Right for every share held on the record date. Six (6) Subscription Rights entitles to subscribe for one (1) new share in the Company.
Comments for offer & related information
The Company issues 1.767.570 shares. The Rights issue is secured via subscription commitments and guarantee commitments for SEK 22 million, corresponding to 73.2 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 73.2 percent.
Other documents
Type
Price
Pre-money
Time
Files
Directed issue
6.50 SEK
77.35M SEK
11 Feb 2014
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription date
11 Feb 2014
Subscription price
Price per share
6.50 SEK
Target to raise
7 646 400 SEK
Types
Share issue
Pre-money valuation
77.35M SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed share issue towards to the US institution.
Comments for offer & related information
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
2.65 SEK
34.65M SEK
14 Apr - 28 Apr 2015
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
14 Apr - 28 Apr 2015
Subscription price
2.65 SEK
Price per share
2.65 SEK
Target to raise
23 100 700 SEK
Types
Share issue
Pre-money valuation
34.65M SEK
Subscription block size
Minimum subscription
Record date
10 Apr 2015
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 2:3. Shareholders receive one (1) Subscription Right for every share held on the record date. Three (3) Subscription Rights entitles to subscribe for two (2) new shares in the Company.
Comments for offer & related information
The Company issues 8.717.273 new shares. The Rights issue is 100 percent secured via guarantee commitments.
Result of offer
The Rights issue subscription ratio corresponded to 100 percent.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
1.10 SEK
23.97M SEK
25 Feb - 09 Mar 2016
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
25 Feb - 09 Mar 2016
Subscription price
1.10 SEK
Price per share
1.10 SEK
Target to raise
17 979 300 SEK
Types
Share issue
Pre-money valuation
23.97M SEK
Subscription block size
Minimum subscription
Record date
23 Feb 2016
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 3:4. Shareholders receive one (1) Unit Right for every share held on the record date. Four (4) Unit Rights entitles to subscribe for three (3) Units. One (1) Unit consists of one (1) share and one (1) free of charge warrant of series TO1.
Comments for offer & related information
The Company issues 16.344.887 Units. One (1) Unit consists of one (1) share and one (1) free of charge warrant of series TO1. One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to seventy (70) percent of a volume-weighted average share price during the period October 3, 2016 - October 14, 2016. The subscription of shares with the support of warrants will take place during the period from October 17, 2016 - October 28, 2016.
The Rights issue is 100 percent secured via subscription commitments and guarantee commitments.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
2.34 SEK
125.09M SEK
28 Nov - 12 Dec 2017
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
28 Nov - 12 Dec 2017
Subscription price
2.34 SEK
Price per share
2.34 SEK
Target to raise
41 697 800 SEK
Types
Share issue
Pre-money valuation
125.09M SEK
Subscription block size
Minimum subscription
Record date
24 Nov 2017
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 1:3. Shareholders receive one (1) Unit Right for every share held on the record date. Three (3) Unit Rights entitles to subscribe for one (1) Unit. One (1) Unit consists of one (1) share and one (1) warrant of serie TO2.
Comments for offer & related information
The Company issues 17.819.573 units. One (1) Unit consists of one (1) share and one (1) warrant of serie TO2. One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the volume weighted average trading price during the period November 12, 2018 - November 23, 2018. Subscription with the support of the warrants will take place during the period November 26, 2018 - December 7, 2018.
The Rights issue is secured via subscription commitments and guarantee commitments for SEK 32.8 million, corresponding to 78.6 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 78.6 percent.
Other documents
Type
Price
Pre-money
Time
Files
Set-off issue
0.24 SEK
17.1M SEK
20 Dec 2018
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription date
20 Dec 2018
Subscription price
Price per share
0.24 SEK
Target to raise
Types
Share issue
Pre-money valuation
17.1M SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Set-off issue related with VisMederi Srl.
Comments for offer & related information
The Company issues 13.652.101 new shares for SEK 3.276.504.
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
0.11 SEK
9.34M SEK
25 Mar - 08 Apr 2019
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
25 Mar - 08 Apr 2019
Subscription price
0.11 SEK
Price per share
0.11 SEK
Target to raise
15 562 900 SEK
Types
Share issue
Pre-money valuation
9.34M SEK
Subscription block size
Minimum subscription
Record date
21 Mar 2019
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 5:3. Shareholders receive one (1) Subscription Right for every share held on the record date. Three (3) Subscription Rights entitles to subscribe for five (5) new shares in the Company.
Comments for offer & related information
The Company issues 141.481.780 new shares. The Rights issue is secured via subscription commitments for SEK 14 million, corresponding to 90 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 90.1 percent.
Other documents
Type
Price
Pre-money
Time
Files
Directed issue
0.1187 SEK
25.2M SEK
14 Oct 2019
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription date
14 Oct 2019
Subscription price
Price per share
0.1187 SEK
Target to raise
2 374 000 SEK
Types
Share issue
Pre-money valuation
25.2M SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed share issue towards to Fårö Capital AB and Eastbridge Capital AB.
Comments for offer & related information
Other documents
Type
Price
Pre-money
Time
Files
Rights issue
0.053 SEK
12.31M SEK
21 Jan - 04 Feb 2020
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
21 Jan - 04 Feb 2020
Subscription price
0.318 SEK
Price per share
0.053 SEK
Target to raise
14 775 200 SEK
Types
Share issue
Pre-money valuation
12.31M SEK
Subscription block size
Minimum subscription
Record date
16 Jan 2020
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preferential right 6:5. Shareholders receive one (1) Unit Right for every share held on the record date. Five (5) Unit Rights entitles to subscribe for one (1) Unit. One (1) Unit consists of six (6) shares and six (6) free of charge warrants of series TO3.
Comments for offer & related information
The Company issues up to 46.462.990 Units. One (1) Unit consists of six (6) shares and six (6) free of charge warrants of series TO3. One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to (70) percent of the average volume-weighted price during 10 trading days ending before the exercise period begins. The subscription with the support of warrants will take place from June 1, 2020 - June 12, 2020.
The Rights issue is secured via subscription commitments and guarantee commitments for SEK 3.02 million, corresponding to 21 percent from the issue volume.
Result of offer
The Rights issue subscription ratio corresponded to 164 percent.
Other documents
Type
Ticker
ISIN
Market
SHARE
EUCI
SE0015382155
Spotlight Stock Market
Sweden (SE)
Details of share in Eurocine Vaccines AB with ticker EUCI
Status
Active
Order book id
4102
Amount of instruments
7 895 413
Par value
0.2500
Currency
SEK
Type
Price
Pre-money
Time
Files
Rights issue
4.00 SEK
31.58M SEK
07 Jun - 21 Jun 2021
Share issue in Eurocine Vaccines AB
Market
Spotlight Stock Market
Subscription period
07 Jun - 21 Jun 2021
Subscription price
8.00 SEK
Price per share
4.00 SEK
Target to raise
31 581 600 SEK
Types
Share issue
Pre-money valuation
31.58M SEK
Subscription block size
Minimum subscription
Record date
03 Jun 2021
Offer status
Active
Listing status
Listed
 
Issue terms
Rights issue. Preferential right 1:1. Shareholders receive one (1) Unit Right for every share held on the record date. One (1) Unit Right entitles to subscribe for one (1) Unit. One (1) Unit consists of two (2) shares and one (1) free of charge warrant of series TO4.
Comments for offer & related information
The Company issues 3.947.706 Units. One (1) Unit consists of two (2) shares and one (1) free of charge warrant of series TO4. One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the average volume-weighted trading price during the period of ten (10) trading days ending two (2) banking days before exercise period begins, but not higher than SEK 5.0 per share. Subscription with the support of warrants will take place from March 14, 2022 - March 28, 2022.
The Rights issue is secured via subscription commitments and guarantee commitments for SEK 25 million, corresponding to 80 percent from the issue volume.
Update (11.06.2021): Interviews with CEO Hans Arwidsson.
Other documents
Type
Ticker
ISIN
Market
OPTION
EUCI TO1
SE0008092555
Spotlight Stock Market
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO1
Status
Archived
Order book id
121659
Amount of instruments
16 344 885
Currency
SEK
Trading period
02 May 2016 - 26 Oct 2016
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to seventy (70) percent of a volume-weighted average share price during the period October 3, 2016 - October 14, 2016. The subscription of shares with the support of warrants will take place during the period from October 17, 2016 - October 28, 2016.
Update (17.10.2016): Eurocine Vaccines initiates the exercise of warrants TO1 at the price of SEK 2.34.
Update (21.10.2016): Last day for trading with warrants TO1 is October 26, 2016.
Type
Price
Pre-money
Time
Files
Exercise
2.34 SEK
151.71M SEK
17 Oct - 28 Oct 2016
Option exercise terms for EUCI TO1
Former ticker
EUCI TO 1
Market
Spotlight Stock Market
Exercise period(s)
17 Oct - 28 Oct 2016
Exercise price
2.34 SEK
Status
Closed
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to seventy (70) percent of a volume-weighted average share price during the period October 3, 2016 - October 14, 2016. The subscription of shares with the support of warrants will take place during the period from October 17, 2016 - October 28, 2016.
Update (17.10.2016): Eurocine Vaccines initiates the exercise of warrants TO1 at the price of SEK 2.34.
Update (21.10.2016): Last day for trading with warrants TO1 is October 26, 2016.
Result of offer
Eurocine Vaccines´ warrants of series TO1 subscription ratio corresponded to 94 percent.
Other documents
Type
Ticker
ISIN
Market
OPTION
EUCI TO2
SE0010599878
Spotlight Stock Market
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO2
Status
Archived
Order book id
4683
Amount of instruments
14 015 388
Currency
SEK
Trading period
31 Jan 2018 - 05 Dec 2018
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the volume weighted average trading price during the period November 12, 2018 - November 23, 2018. Subscription with the support of the warrants will take place during the period November 26, 2018 - December 7, 2018.
Update (24.01.2018): Trading in warrants series TO2 will commence on January 31, 2018.
Update (26.11.2018): The subscription price has been calculated - SEK 0.24.
Type
Price
Pre-money
Time
Files
Exercise
0.24 SEK
16.3M SEK
26 Nov - 07 Dec 2018
Option exercise terms for EUCI TO2
Former ticker
EUCI TO 2
Market
Spotlight Stock Market
Exercise period(s)
26 Nov - 07 Dec 2018
Exercise price
0.24 SEK
Status
Closed
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the volume weighted average trading price during the period November 12, 2018 - November 23, 2018. Subscription with the support of the warrants will take place during the period November 26, 2018 - December 7, 2018.
Update (24.01.2018): Trading in warrants series TO2 will commence on January 31, 2018.
Update (26.11.2018): The subscription price has been calculated - SEK 0.24.
Result of offer
Eurocine Vaccines´ warrants of series TO2 subscription ratio corresponded to 24 percent.
Other documents
Type
Ticker
ISIN
Market
OPTION
EUCI TO3
SE0013668258
Spotlight Stock Market
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO3
Status
Archived
Order book id
5XU4
Amount of instruments
278 777 940
Currency
SEK
Trading period
04 Mar 2020 - 12 Jun 2020
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to (70) percent of the average volume-weighted price during 10 trading days ending before the exercise period begins. The subscription with the support of warrants will take place from June 1, 2020 - June 12, 2020.
Update (26.05.2020): Eurocine Vaccines has agreed on subscription links and guarantee subscriptions corresponding to approximately 28 percent of the issue volume for TO3.
Update (29.05.2020): Eurocine Vaccines announces subscription price for warrants of series TO3 - SEK 0.087.
Update (10.06.2020): The last day for exercise of warrants TO3 is June 12, 2020.
Type
Price
Pre-money
Time
Files
Exercise
0.087 SEK
61.3M SEK
01 Jun - 12 Jun 2020
Option exercise terms for EUCI TO3
Former ticker
EUCI TO 3
Market
Spotlight Stock Market
Exercise period(s)
01 Jun - 12 Jun 2020
Exercise price
0.087 SEK
Status
Closed
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to (70) percent of the average volume-weighted price during 10 trading days ending before the exercise period begins. The subscription with the support of warrants will take place from June 1, 2020 - June 12, 2020.
Update (26.05.2020): Eurocine Vaccines has agreed on subscription links and guarantee subscriptions corresponding to approximately 28 percent of the issue volume for TO3.
Update (29.05.2020): Eurocine Vaccines announces subscription price for warrants of series TO3 - SEK 0.087.
Update (10.06.2020): The last day for exercise of warrants TO3 is June 12, 2020.
Result of offer
Eurocine Vaccines´ warrants of series TO3 subscription ratio corresponded to 72 percent.
Other documents
Type
Ticker
ISIN
Market
OPTION
EUCI TO4
Spotlight Stock Market
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO4
Status
Inactive
Order book id
Amount of instruments
Currency
SEK
First trading date
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the average volume-weighted trading price during the period of ten (10) trading days ending two (2) banking days before exercise period begins, but not higher than SEK 5.0 per share.
Type
Price
Pre-money
Time
Files
Exercise
14 Mar - 28 Mar 2022
Option exercise terms for EUCI TO4
Former ticker
EUCI TO4-A-2021
Market
Spotlight Stock Market
Exercise period(s)
14 Mar - 28 Mar 2022
Exercise price
Status
Upcoming
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the average volume-weighted trading price during the period of ten (10) trading days ending two (2) banking days before exercise period begins, but not higher than SEK 5.0 per share.
Other documents
People
Hans Arwidsson
CEO
Pierre Morgon
Chairman of the board
Hans Arwidsson
Board member
Emanuele Montomoli
Board member
Jan Sandström
Board member
Pär Thuresson
Board member
Company Details
Sector
HEALTH CARE

Address
Nanna Svartz väg 4
Zip code
171 65
City/district
Solna
Country
Sweden (SE)
Registration number
556566-4298
LEI code
549300B408R6FTXR0D15
First trade date
12 Dec 2006
Registration date
15 Feb 1999
Short name
EV

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More